Interest Expense in USD of NeuBase Therapeutics, Inc. from Q2 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
NeuBase Therapeutics, Inc. quarterly and annual Interest Expense history and change rate from Q2 2010 to Q3 2023.
  • NeuBase Therapeutics, Inc. Interest Expense for the quarter ending 30 Sep 2023 was $122, a 95.5% decline year-over-year.
  • NeuBase Therapeutics, Inc. Interest Expense for the twelve months ending 30 Sep 2023 was $5,074, a 78.9% decline year-over-year.
  • NeuBase Therapeutics, Inc. annual Interest Expense for 2022 was $24,047, a 25.6% decline from 2021.
  • NeuBase Therapeutics, Inc. annual Interest Expense for 2021 was $32,330, a 321% increase from 2020.
  • NeuBase Therapeutics, Inc. annual Interest Expense for 2020 was $7,686, a 94% decline from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

NeuBase Therapeutics, Inc. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $5,074 $122 -$2,571 -95% 01 Jul 2023 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $7,645 $730 -$2,089 -74% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $9,734 $2,354 -$962 -29% 01 Jan 2023 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $10,696 $1,868 -$13,351 -88% 01 Oct 2022 31 Dec 2022 10-QT 05 Jun 2023 2022 Q1
Q3 2022 $24,047 $2,693 -$10,366 -79% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $34,413 $2,819 -$255 -8.3% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $34,668 $3,316 -$3,144 -49% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $37,812 $15,219 +$5,482 +56% 01 Oct 2021 31 Dec 2021 10-QT 05 Jun 2023 2022 Q1
Q3 2021 $32,330 $13,059 +$8,599 +193% 01 Jul 2021 30 Sep 2021 10-K 21 Dec 2022 2022 FY
Q2 2021 $23,731 $3,074 +$1,501 +95% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q3
Q1 2021 $22,230 $6,460 +$6,118 +1,789% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q2
Q4 2020 $16,112 $9,737 +$8,426 +643% 01 Oct 2020 31 Dec 2020 10-Q 11 Feb 2022 2022 Q1
Q3 2020 $7,686 $4,460 -$5,296 -54% 01 Jul 2020 30 Sep 2020 10-K 23 Dec 2021 2021 FY
Q2 2020 $12,982 $1,573 -$59,371 -97% 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021 2021 Q3
Q1 2020 $72,353 $342 -$43,272 -99% 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021 2021 Q2
Q4 2019 $115,625 $1,311 -$13,326 -91% 01 Oct 2019 31 Dec 2019 10-Q 11 Feb 2021 2021 Q1
Q3 2019 $128,951 $9,756 +$9,016 +1,218% 01 Jul 2019 30 Sep 2019 10-K 23 Dec 2020 2020 FY
Q2 2019 $119,935 $60,944 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020 2020 Q3
Q1 2019 $43,614 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020 2020 Q2
Q4 2018 $14,637 01 Oct 2018 31 Dec 2018 10-Q 26 Mar 2020 2020 Q1
Q3 2018 $740 28 Aug 2018 30 Sep 2018 10-K 10 Jan 2020 2019 FY
Q3 2015 $5,977 $1,620 01 Jul 2015 30 Sep 2015 10-K 14 Dec 2015 2015 FY
Q2 2015 $2,824 -$758 -21% 01 Apr 2015 30 Jun 2015 10-Q 06 Aug 2015 2015 Q3
Q1 2015 $1,100 01 Jan 2015 31 Mar 2015 10-Q 11 May 2015 2015 Q2
Q4 2014 $433 -$80 -16% 01 Oct 2014 31 Dec 2014 10-Q 10 Feb 2015 2015 Q1
Q2 2014 $3,582 +$594 +20% 01 Apr 2014 30 Jun 2014 10-Q 06 Aug 2015 2015 Q3
Q4 2013 $513 -$46 -8.2% 01 Oct 2013 31 Dec 2013 10-Q 10 Feb 2015 2015 Q1
Q2 2013 $2,988 +$2,082 +230% 01 Apr 2013 30 Jun 2013 10-Q 18 Aug 2014 2014 Q3
Q4 2012 $559 01 Oct 2012 31 Dec 2012 10-Q 14 Feb 2014 2014 Q1
Q2 2012 $906 +$822 +979% 01 Apr 2012 30 Jun 2012 10-Q 13 Aug 2013 2013 Q3
Q3 2011 $2,433 $0 01 Jul 2011 30 Sep 2011 10-K 09 Jan 2013 2012 FY
Q2 2011 $84 -$2,411 -97% 01 Apr 2011 30 Jun 2011 10-Q 07 Aug 2012 2012 Q3
Q1 2011 $169 01 Jan 2011 31 Mar 2011 10-Q 11 May 2012 2012 Q2
Q4 2010 $2,180 01 Oct 2010 31 Dec 2010 10-Q/A 14 Feb 2012 2012 Q1
Q2 2010 $2,495 01 Apr 2010 30 Jun 2010 10-Q 15 Aug 2011 2011 Q3

NeuBase Therapeutics, Inc. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $24,047 -$8,283 -26% 01 Oct 2021 30 Sep 2022 10-K 21 Dec 2022 2022 FY
2021 $32,330 +$24,644 +321% 01 Oct 2020 30 Sep 2021 10-K 21 Dec 2022 2022 FY
2020 $7,686 -$121,265 -94% 01 Oct 2019 30 Sep 2020 10-K 23 Dec 2021 2021 FY
2019 $128,951 01 Oct 2018 30 Sep 2019 10-K 23 Dec 2020 2020 FY
2015 $5,977 +$401 +7.2% 01 Oct 2014 30 Sep 2015 10-K 14 Dec 2015 2015 FY
2014 $5,576 +$887 +19% 01 Oct 2013 30 Sep 2014 10-K 14 Dec 2015 2015 FY
2013 $4,689 +$2,872 +158% 01 Oct 2012 30 Sep 2013 10-K 14 Dec 2015 2015 FY
2012 $1,817 -$616 -25% 01 Oct 2011 30 Sep 2012 10-K 22 Dec 2014 2014 FY
2011 $2,433 -$19,060 -89% 01 Oct 2010 30 Sep 2011 10-K 09 Jan 2013 2012 FY
2010 $21,493 01 Oct 2009 30 Sep 2010 10-K/A 18 Jan 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.